Key result
Higher epicardial adipose tissue T1 mapping links to worse myocardial injury and lower LVEF in STEMI.
Why the study?
While CMR enables detailed myocardial tissue characterization in STEMI, quantitative in vivo mapping of epicardial adipose tissue using T1 and T2 mapping had not been systematically explored.
Does CMR-based T1 and T2 mapping of epicardial adipose tissue correlate with myocardial injury severity and systemic inflammation in patients with acute STEMI compared to stable coronary artery disease controls?
Observational (n=21)
Does CMR-based T1 and T2 mapping of epicardial adipose tissue correlate with myocardial injury severity and systemic inflammation in patients with acute STEMI compared to stable coronary artery disease controls?
CMR-based quantitative T1 and T2 mapping of epicardial adipose tissue is feasible in acute STEMI and correlates with the severity of myocardial injury and systemic inflammatory activation.
EAT T1 mapping was associated with injury severity in acute STEMI; hypothesis-generating and requires prospective validation before clinical adoption.
Background Epicardial adipose tissue (EAT) is a metabolically active visceral fat depot with paracrine inflammatory properties implicated in coronary plaque instability. While cardiovascular magnetic resonance (CMR) enables detailed myocardial tissue characterization in ST-elevation myocardial infarction (STEMI), quantitative in vivo mapping of EAT has not been systematically explored. We aimed to assess EAT tissue characteristics using T1 and T2 mapping in acute STEMI and evaluate associations with myocardial injury and systemic inflammation. Methods We prospectively studied 12 patients with acute STEMI undergoing CMR in the acute phase and 9 patients with stable coronary artery disease as controls. The CMR protocol included LV volumes and ejection fraction (EF), late gadolinium enhancement (LGE), native myocardial T1 and T2 mapping, and extracellular volume (ECV). EAT thickness was measured in the 4-chamber view, and native T1 and T2 mapping were performed within EAT regions of interest. Serum IL-6 and NT-proBNP levels were obtained. Group comparisons were performed using Mann–Whitney U test and correlations using Spearman analysis. Results STEMI patients demonstrated higher myocardial T1/T2 and ECV compared with controls (p≤0.04). Within the STEMI cohort, EAT T1 mapping correlated inversely with EF (ρ=−0.62, p=0.031) and positively with LGE burden (ρ=0.64, p=0.023), infarct segment number (ρ=0.60, p=0.033), and ECV (ρ=0.57, p=0.048). EAT T2 mapping showed similar associations with EF (ρ=−0.60, p=0.038) and LGE (ρ=0.62, p=0.028). EAT thickness demonstrated weaker correlations compared with mapping parameters. IL-6 correlated with LGE (ρ=0.69, p=0.014), ECV (ρ=0.60, p=0.036), and EF (ρ=−0.65, p=0.023), and showed moderate positive associations with EAT mapping values, supporting a link between epicardial tissue remodeling and systemic inflammatory activation. Conclusions CMR-based quantitative characterization of epicardial adipose tissue is feasible in acute STEMI. Increased EAT T1 and T2 values are associated with myocardial injury severity and inflammatory activation, beyond simple volumetric assessment. These findings suggest that EAT mapping may provide incremental insight into myocardial–epicardial inflammatory interplay following STEMI. Larger studies are warranted to validate these exploratory observations.
No takes yet. Share an insight, caveat, or question.
Zafirovska et al. (2026) conducted an observational in Acute ST-elevation myocardial infarction (STEMI) (n=21). Cardiovascular magnetic resonance (CMR) T1 and T2 mapping of epicardial adipose tissue (EAT) vs. Stable coronary artery disease controls was evaluated on Association of EAT T1 and T2 mapping with myocardial injury (EF, LGE burden, infarct segment number, ECV) and systemic inflammation (IL-6) (ρ=0.64 (EAT T1 with LGE), p=0.023). Epicardial adipose tissue T1 mapping in acute STEMI correlated inversely with LVEF (ρ=−0.62, p=0.031) and positively with LGE burden (ρ=0.64, p=0.023) and ECV (ρ=0.57, p=0.048).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: